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Abstract
Background: Genomic instability promotes evolution and heterogeneity of tumors. Unraveling its mechanistic basis
is essential for the design of appropriate therapeutic strategies. In a previous study, we reported an unexpected
oncogenic property of p21WAF1/Cip1, showing that its chronic expression in a p53-deficient environment causes genomic
instability by deregulation of the replication licensing machinery.
Results: We now demonstrate that p21WAF1/Cip1 can further fuel genomic instability by suppressing the repair capacity
of low- and high-fidelity pathways that deal with nucleotide abnormalities. Consequently, fewer single nucleotide
substitutions (SNSs) occur, while formation of highly deleterious DNA double-strand breaks (DSBs) is enhanced,
crafting a characteristic mutational signature landscape. Guided by the mutational signatures formed, we find
that the DSBs are repaired by Rad52-dependent break-induced replication (BIR) and single-strand annealing (SSA)
repair pathways. Conversely, the error-free synthesis-dependent strand annealing (SDSA) repair route is deficient.
Surprisingly, Rad52 is activated transcriptionally in an E2F1-dependent manner, rather than post-translationally as
is common for DNA repair factor activation.
Conclusions: Our results signify the importance of mutational signatures as guides to disclose the repair history
leading to genomic instability. We unveil how chronic p21WAF1/Cip1 expression rewires the repair process and identifies
Rad52 as a source of genomic instability and a candidate therapeutic target.
Keywords: p21WAF1/Cip1, Rad52, Genomic instability, Translesion DNA synthesis (TLS), Single nucleotide substitution
(SNS), Break-induced replication (BIR), Single strand annealing (SSA)
Background
Genomic instability is a hallmark of cancer that plays an
important role in shaping tumor behavior over time [1–5].
Elucidating the molecular routes that drive this
phenomenon is essential for designing proper therapeutic
strategies as well as monitoring the natural history of
carcinogenesis [6]. Not all genetic alterations are driver
events, since each type of cancer bears a large number of
passenger mutations [7]. Although the latter have no
causative role in cancer development, they represent
pieces of a mutational signature pattern that can provide
information about the type(s) of DNA damage taking
place and the repair pathway(s) involved [7, 8].
We have recently reported that precancerous- and
cancerous-associated chronic p21WAF1/Cip1 expression, in a
p53-deficient environment, fuels genomic instability by de-
regulating the replication licensing machinery, causing re-
replication, a deleterious form of replication stress. These
events occur throughout a senescence-like phase during
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which an error-prone DNA repair process takes place,
forming a genetic landscape that allows a subpopulation of
p21WAF1/Cip1–expressing cells to escape senescence
(termed “escaped” cells) [9]. Interestingly, and in accord-
ance with the oncogene-induced DNA damage model for
cancer development [4], the escaped cells demonstrated
aggressive features and increased chemo-resistance [9].
Which particular error-prone repair pathway(s) is(are)
employed by the p21WAF1/Cip1-expressing cells to craft the
permissive environment for “senescence escape” is a key
question, as its answer would unveil potential genomic
instability routes that could represent future therapeutic
targets. To address this question we followed a reverse en-
gineering approach examining the mutational signature
patterns of the escaped cells (Additional file 1: Figure S1).
The mutational signatures that include amount and type
of single nucleotide substitutions (SNSs), insertions and
deletions (INDELs), and breakpoint junctions reflect the
actual “repair history” that takes place following exogen-
ous and/or endogenous mutagenic events. As a guideline
we utilized the 21 distinct mutational signatures reported
by Alexandrov and collegues, who extracted them after
analyzing ~ 5 × 106 mutations from ~ 7000 cancers [8].
We demonstrate that p53-independent elevated p21WAF1/
Cip1 expression drives genomic instability by rewiring the
global cellular DNA repair landscape towards predomin-
antly error-prone processes that prominently rely on the
RAD52 recombinase.
Results
The SNS load is reduced in p21WAF1/Cip1 escaped cells
As a first step we evaluated the SNS load in the human
p21WAF1/Cip1 escaped cell models [9], following the experi-
mental algorithm described in Additional file 1: Figure S1.
We found that they harbor fewer SNSs compared to the
p21WAF1/Cip1-un-induced controls (Fig. 1a). This result
was cell type independent, consistently observed in both
p21WAF1/Cip1-inducible cellular systems examined, namely
cancerous Saos2 cells and non-cancerous cells from a
Li-Fraumeni syndrome patient (Fig. 1a). Given that pro-
tracted p21WAF1/Cip1 expression in a p53-null environment
promotes genomic instability [9], the reduced number of
SNSs in the escaped cells seemed at first glance counterin-
tuitive. Yet, from a broader perspective, even though SNSs
represent genetic defects, they signify the “last option” the
cell possesses to avoid the more detrimental double strand
break (DSB) lesions [7]. Translesion DNA synthesis (TLS)
or DNA damage tolerance (DDT) is the main cellular re-
pair mode that orchestrates the choice of the above men-
tioned last option by dealing with all types of SNSs that
remain unrepaired by the cellular high-fidelity repair
mechanisms (Additional file 1: Figure S2b). TLS is also
known as post-replication repair (PRR) as it initiates DNA
synthesis downstream of a DNA lesion, thus allowing
repair after DNA synthesis (Fig. 1b) [10, 11]. Hence, the
reduced amount of SNSs in the escaped cells could result
from a malfunctioning TLS/DDT repair process and/or
reduced activity of one or more high-fidelity repair
pathways that commonly mend defective nucleotides
(Additional file 1: Figure S2c).
Reduced SNS load reflects malfunctioning TLS and
nucleotide excision repair (NER) and base excision repair
(BER) pathways
A key step regulating TLS is monoubiquitination of
PCNA (Ub-PCNA), at Lys 164 (K164), carried out by the
E3-ligase Rad18 [12]. Such monoubiquitinated PCNA
(Mono-Ub-PCNA) operates as a “molecular switch”, shift-
ing normal DNA replication into TLS. Mono-Ub-PCNA
increases its affinity for TLS polymerase Polη, a Y-family
polymerase that inserts a nucleotide directly opposite a
nucleotide lesion (Fig. 1b) [13]. Although Polη is involved
in error-free lesion bypass of UV-induced thymidine (TT)
dimers [14, 15], it can also catalyze error-prone bypass of
other lesion types such as 8-oxoguanine, apurinic/apyrimi-
dinic (AP) sites, and DNA adducts caused by benzo[a]pyr-
ene diol epoxide (BPDE), leading to mutagenic
consequences [16]. Following p21WAF1/Cip1 induction,
both the mono-Ub-PCNA and the chromatin bound
fraction of Polη were dramatically reduced, consistent
with our conjecture that dysfunctional TLS may be
responsible for the reduced SNS load in the escaped cells
(Fig. 1c, d). In line with the above, recruitment of Polκ, an
extender in translesion synthesis [17], to sites of UV-laser
induced DNA damage was significantly decreased in cells
expressing p21WAF1/Cip1 (Fig. 1e; Additional files 2, 3, 4,
and 5). Supporting the notion that the induced p21WAF1/
Cip1 binds to and inhibits PCNA monoubiquitination, and
consequently reduces recruitment of the TLS polymerases
[18], replacing the wild-type p21WAF1/Cip1 by a p21 mutant
defective in PCNA binding (p21PCNA) did not reduce
PCNA monoubiquitination (Fig. 1f). To assess whether
the above biochemical traits reflect dysfunctional TLS re-
pair we employed a gapped plasmid TLS assay [19] to
quantify the extent of repair across a site-specific (ben-
zo[a]pyrene-guanine) adduct and found that induction of
p21WAF1/Cip1 resulted in a robustly decreased (4.6–7.1-
fold) frequency and concomitantly lower repair accuracy
(12 instead of 37 %) (Fig. 1g; Additional file 6: Table S1).
An additional feature that could further exacerbate the
impact of malfunctioning TLS-mediated repair would be
potentially increased numbers of erroneous nucleotides in
the genome due to deregulation of the high-fidelity nu-
cleotide repair mechanisms. It has been reported that
p21WAF1/Cip1 can negatively modulate high-fidelity DNA
repair processes, particularly those implicated in excising
defective nucleotides, such as nucleotide excision repair
(NER), mismatch repair (MMR), and base excision repair
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(BER) [20]. Given that our experimental systems were not
exposed to exogenous causes of DNA damage, such as
UV or X-ray irradiation, a major potential source of nu-
cleotide abnormalities could be an endogenous process,
particularly over-production of reactive oxygen species
(ROS) [21]. Elevated ROS would lead to nucleotide oxida-
tive lesions, with 8-oxo-dGuanine (8-oxo-dG) being the
most frequent [22]. Indeed, p21WAF1/Cip1 induction was
A
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Fig. 1 Reduction of single nucleotide substitution (SNS) and malfunction of the translesion DNA synthesis and repair (TLS) process upon protracted
p21WAF1/Cip1 expression. a Chronic p21WAF1/Cip1 expression, in a p53-deficient environment, leads to the emergence of a subpopulation of p21WAF1/Cip1
aggressive and chemo-resistant (escaped (ESC)) cells, after bypassing an initial senescence-like phase, that carry a lower SNS “load” [9]. SNS identification
and filtering were performed with the use of Samtools and VCFtools in non-induced and escaped (Saos2- and Li-Fraumeni-p21WAF1/Cip1 Tet-ON) cells
(see also Additional file 1: Figure S1), depicted in accompanying histograms (*p < 0.05 (Saos2 and Li-Fraumeni), OFF vs ESC, Welch’s t-test) (for details
see “Methods” section). b TLS pathway function. TLS is a DNA damage tolerance process enabling the DNA replication machinery to replicate over
DNA lesions. Upon DNA damage PCNA is mono-ubiquitinated, followed by polymerase switch from normal high-fidelity DNA replication polymerases
to TLS ones. TLS polymerase Polη, bound to PCNA, inserts a nucleotide opposite to the lesion and, assisted or not by an additional TLS polymerase like
Polκ or Polζ, extends beyond the insertion. Finally, a second polymerase switch takes place by substituting TLS polymerases with high-fidelity ones.
c Sustained p21WAF1/Cip1 expression results in decreased mono-ubiquitination of PCNA (mono-Ub). Immunoblots (IBs) in 96-h induced Saos2- and
Li-Fraumeni-p21WAF1/Cip1 Tet-ON cells (n = 3 experiments). d Reduced binding of Polη to chromatin in cells with protracted p21WAF1/Cip1 expression. IBs
after cell fractionation (described in scheme) depicting lower levels of Polη in chromatin extracts from 96-h induced Saos2- and Li-Fraumeni-p21WAF1/
Cip1 Tet-ON cells (n = 3 experiments). e Immunofluorescent confocal microscopy (top panel) showing reduced Polκ loading on regions of damaged
chromatin after UV-laser ablation in 96-h induced Saos2-p21WAF1/Cip1 Tet-ON cells transfected with a GFP-Polκ vector. Plots (lower panel) depict
recruitment kinetics of Polκ in Saos2- and Li-Fraumeni- p21WAF1/Cip1 Tet-ON cells, respectively (see also Additional files 2, 3, 4 and 5). The average intensity
of fluorescence at the site of damage and the total cell fluorescence with respect to time were quantified and plotted. Five cells in each condition of
three independent experiments were processed. Time frames for obtaining IFs and recruitment plots are depicted in middle panel. f A specific p21WAF1/
Cip1 mutant (p21PCNA; harboring Q144, M147, F150 substitutions to A in its PCNA-interacting-protein (PIP) degron motif) with an abrogated interaction
with PCNA [9]. IBs depict mono-ubiquitination of PCNA (mono-Ub) in 96-h induced Saos2- and Li-Fraumeni-p21PCNA Tet-ON cells (n = 3 experiments). g
Overexpression of p21WAF1/Cip1 decreases TLS repair efficiency across a site-specific lesion in a gapped plasmid TLS assay (i). Induced Li-Fraumeni-p21WAF1/
Cip1 Tet-ON cells were assayed for TLS efficiency (ii) and accuracy of repair (iii) with a gap-lesion vector carrying a site-specific benzo[a]pyrene-guanine
(BP-G) adduct (i) (Additional file 6: Table S1) (n = 3 experiments). Actin and lamin B serve as loading control (* p < 0.05, error bars indicate SDs). MQ
mapping quality, AF allele frequency, DP sequencing depth, MCM Mini-Chromosome Maintenance protein complex, RPA Replication Protein A, WCE
whole cell extract, S2 soluble cytosolic, S3 soluble nuclear, P3 chromatin-nuclear matrix
Galanos et al. Genome Biology  (2018) 19:37 Page 3 of 18
followed by a progressive generation of ROS (Fig. 2a), in
agreement with previous findings [23]. Applying a modi-
fied version of the alkaline Comet assay, we could detect
oxidized purines (like 8-oxo-dG) in the DNA of the
p21WAF1/Cip1-induced cells using OGG1 (8-oxoguanine
glycosylase) as a damage probe (Fig. 2). Moreover,
RNAseq and protein analysis showed that essential factors
of the nucleotide repair mechanisms were down-regulated
(Figs. 2 and 3; Additional file 1: Figures S3 and S4). BER,
which is mainly responsible for removing oxidative lesions
[22], was particularly affected, as the levels of several key
DNA glycosylases and downstream effectors were down-
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Fig. 2 Decreased activity of the base excision repair (BER) pathway in cells with sustained p21WAF1/Cip1 expression. a Increased reactive species
(RS) levels were assessed with a DCFH-DA assay in Saos2 (i) and Li-Fraumeni (ii) cells with protracted p21WAF1/Cip1 expression (*p < 0.05 (Saos2),
*p = 0.05 (Li-Fraumeni), t-test; error bars indicate standard deviation; n = 5 experiments). As shown in the middle panel RS production can lead to
generation of base/nucleotide oxidative lesions. b RNAseq analysis showed that essential factors of the BER pathway were statistically significantly
down-regulated (p ≤ 0.05) in 96-h induced Saos2- (i) and Li-Fraumeni- (ii) p21WAF1/Cip1 Tet-ON cells (see also Additional file 1: Figure S3 for specific
real time RT-PCR validation). Note that although in Saos2- p21WAF1/Cip1 Tet-ON cells OGG1 expression was not found by RNAseq analysis, specific
real-time RT-PCR and microarray analysis (see also Additional file 1: Figure S3) [9] confirmed its decreased expression. Selective immunoblots for
APEX1, LIG3, TDG, and MUTY confirmed the specificity of the RNA analysis results. Note that LIG3 participates also in mismatch repair (MMR;
Additional file 1: Figure S3). α-Tubulin served as loading control. c Modified alkaline Comet assay demonstrated the presence of oxidized purines like
8-oxo-dG in 96-h induced Saos2- (i) and Li-Fraumeni- (ii) p21WAF1/Cip1 Tet-ON cells, using 8-oxoguanine glycosylase (OGG1) (*p < 0.05 (Saos2), *p = 0.05
(Li-Fraumeni), t-test; error bars indicate standard deviation; n = 5 experiments). Comet data were corroborated by an 8-oxo-dG-specific assay measuring
DNA incorporation of 8-oxo-dG in p21WAF1/Cip1-expressing cells [24], which indicated lower OGG1 activity (*p < 0.05 (Saos2), *p = 0.05 (Li-Fraumeni),
t-test; error bars indicate standard deviation; n = 5 experiments). Consequently, as depicted in the model in the middle panel, recognition and excision
of the affected nucleotide lesion is impaired in the BER process. The middle panel depicts the components and steps during BER. The BER pathway is
responsible for removal of small lesions from DNA, especially oxidized, alkylated, deaminated bases and abasic sites. BER can be induced by oxidative
stress and various genotoxic insults. Its specificity relies on the excision of base damage by glycosylases. In humans, the mechanism of BER involves
the initial action of DNA glycosylases followed by the processing of the resulting abasic site either by the AP-lyase activity of the glycosylases or by the
apurinic/apyrimidic endonucleases APE1/APE2, which incise the DNA strand. The resulting single-strand break can be processed by two BER subpathways.
Either the short-patch branch is engaged, if a single nucleotide is replaced, or the long-patch branch, if 2–10 new nucleotides are synthesized. OGG1
8-oxoguanine DNA glycosylase, UNG uracil DNA glycosylase, TDG thymine DNA glycosylase, SMUG1 single-strand-selective monofunctional uracil-DNA
glycosylase 1, NTH DNA glycosylase and apyrimidinic (AP) lyase (endonuclease III), MBD4 methyl-CpG binding domain 4, DNA glycosylase, MPG
N-methylpurine DNA glycosylase, MUTY adenine DNA glycosylase, NEIL1/2/3 Nei-like DNA glycosylase 1/ 2/ 3, APEX1/2 apurinic/apyrimidinic
endodeoxyribonuclease 1/2, POLB/POLD, DNA polymerase beta/ delta, PCNA proliferating cell nuclear antigen, RFC replication factor C, FEN1
flap structure-specific endonuclease 1, LIG1/LIG3 DNA ligase 1/3, PARP1 poly(ADP-ribose) polymerase 1, XRCC1 X-ray repair cross complementing 1
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regulated (Fig. 2b; Additional file 1: Figures S3 and S4).
Consistently, we found enhanced DNA incorporation of
8-oxo-dG in p21WAF1/Cip1-expressing cells, using an 8-
oxo-dG-specific assay [24], indicative of lower OGG1 ac-
tivity (Fig. 2c). NER was disrupted as well, as judged from
the levels of its components and the repair capacity of N-
alkylpurine monoaducts [25, 26] (Fig. 3; Additional file 1:
Figures S3, S4, and S5). Although NER is primarily
involved in repairing bulky DNA lesions, for instance UV-
induced TT dimers, it can also repair non-bulky nucleo-
tide defects [25]. Of note, a few key BER and NER factors
demonstrated a differential expression pattern (Figs. 2 and
3; Additional file 1: Figure S4). Given the redundant na-
ture of BER glycosylases [22] (Additional file 1: Figure
S4a), and that most suppressed NER factors resided in
DNA damage-recognition complexes (Additional file 1:
Figure S4b), we can infer this seemingly “confusing” result
as a cellular context-based inefficient compensatory
response to restore functionality [27–29].
Overall, due to elevated reactive oxygen species (ROS)
and malfunctioning BER and NER, the amount of unre-
paired oxidative lesions, such as 8-oxo-dG, would increase
Ai
Bi
Aii
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Fig. 3 Decreased activity of the nucleotide excision repair (NER) pathway in cells with prolonged p21WAF1/Cip1 expression. a RNAseq analysis showed that
essential factors of the NER pathway were statistically significantly down-regulated (p ≤ 0.05; see also Additional file 1: Figure S3 for specific real-time
RT-PCR validation) in 96-h induced Saos2- (i) and Li-Fraumeni- (ii) p21WAF1/Cip1 Tet-ON cells. Selective immunoblots for DDB1, ERCC1, ERCC4-XPF, XPC, and
ERCC5-XPG, key factors in NER [22], confirming the specificity of the RT-PCR results. α-Tubulin served as loading control; the same protein extracts were
used as in Fig. 2. b Decreased repair capacity of N-alkylpurine monoadducts in induced Saos2- (i) and Li-Fraumeni- (ii) p21WAF1/Cip1 Tet-ON cells and
treated with monohydroxymelphalan, an inducer of specific NER substrates [69–71]. The data shown are based on five independent experiments with at
least two analyses for independent experiment/independent experiment experiment (* p < 0.05, error bars indicate SDs). The middle panel de-
picts the components and function of NER. The NER pathway is responsible for repair of bulky lesions, especially UV-induced thymine dimers
and 6,4-photoproducts, as well as non-bulky ones. Following DNA damage recognition, a short single-stranded DNA fragment that contains the le-
sion is removed. The remaining undamaged single-stranded DNA segment is used by DNA polymerase as a template to synthesize the complemen-
tary sequence. Final ligation to complete NER and formation of a double-stranded DNA is carried out by DNA ligase. Depending on how the DNA
damage is recognized, NER can be divided into two subpathways: transcription coupled NER (TC-NER) and global genome NER (GG-NER). While the
two subpathways differ in how they recognize DNA damage, they share the same process for lesion incision, repair, and ligation. RBX1 Ring-box 1, Cul4
Cullin 4, DDB1/2 Damage specific DNA binding protein 1/2, ERCC8 (CSA) ERCC excision repair 8, CSA ubiquitin ligase complex subunit, ERCC6
(CSB) ERCC excision repair 6, chromatin remodeling factor, USP7 Ubiquitin-specific peptidase 7; ERCC4-XPF Excision repair 4, endonuclease,
ERCC5-XPG ERCC excision repair 5, endonuclease, XPA XPA, DNA damage recognition and repair factor, XAB2 XPA binding protein 2, RPA
Replication protein A, HMGN1 High mobility group nucleosome binding domain 1; XPC XPC complex subunit, DNA damage recognition
and repair factor, RAD23B RAD23 homolog B, CETN2 Centrin 2, CDK7 Cyclin-dependent kinase 7, MNAT1 CDK activating kinase assembly
factor, CCNH Cyclin H, TFIIH1–4 Transcription/repair factor IIH 1–4, ERCC3 ERCC excision repair 3, TFIIH core complex helicase subunit,
ERCC2 ERCC excision repair 2, TFIIH core complex helicase subunit, TTDA (GTF2H5/TFB5) General transcription factor IIH subunit 5
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over time, further burdening the cells with dysfunctional
TLS. Consequently, apart from re-replicated DNA [9], the
unrepaired nucleotides may represent an additional source
of replication fork stalling, collapse, and DNA DSBs
(Additional file 1: Figure S2c).
Protracted p21WAF1/Cip1 expression fosters
Rad52-dependent break-induced replication (BIR) and
single strand annealing (SSA)
Next we investigated whether mutational signatures
(Fig. 4a; Additional file 1: Figure S1) could guide us to
identify potential repair pathway dysfunction. The
p21WAF1/Cip1 escaped cells demonstrated a similar muta-
tional pattern, in both experimental settings, comprised
of SNSs and INDELs, frequently clustered adjacent to
breakpoints that exhibited microhomologies (Fig. 4a, b).
Interestingly, down-regulation of both BRCA1 and
BRCA2, two critical components of homologous recom-
bination (Additional file 1: Figure S6a) with concurrent
loss of heterozygosity at the BRCA2 locus, was also
observed (Fig. 4c, d). Comparing the above mutational
pattern with the 21 signatures reported by Alexandrov
and colleagues [8] we concluded that it is a novel,
A
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Fig. 4 Extended p21WAF1/Cip1 over-expression shapes the mutational signature landscape. a Escaped (30 days induced) Saos2- and Li-Fraumeni-p21WAF1/
Cip1 Tet-ON cells exhibit specific patterns of single nucleotide substitution (SNS). SNSs with mapping quality above 30 found only in the escaped cells
were filtered based on sequencing depth and scored as ESC-specific (see also Additional file 1: Figure S1). Those SNSs were used to calculate
the mutational signature of ESC versus OFF cells (for details see “Methods” section and Additional file 1: Figure S1). Heat map shows the number of
mutation type at each mutation context, which was corrected for the frequency of each triplet in the human genome (hg19). Histograms present the
mutation-type frequency at each mutation context from two biological replicates of escaped Saos2- and Li-Fraumeni-p21WAF1/Cip1 Tet-ON cells, respectively.
Both presentations show reproducible patterns of the mutational signatures 6, 15, 3 [8]. b Heat map showing the association of SNSs, nucleotide insertions
(INS), and nucleotide deletions (DEL) with the observed chromosomal breakpoints (±50 kb around the breakpoint) versus the remaining
genome in escaped Saos2- and Li-Fraumeni-p21WAF1/Cip1 Tet-ON cells. c Real-time RT-PCR assessment of BRCA1 and BRCA2 mRNA expression in induced
and non-induced Saos2 and Li-Fraumeni p21WAF1/Cip1 Tet-ON cells (*p < 0.05 (Saos2), *p = 0.05 (Li-Fraumeni), t-test; error bars indicate standard deviation;
n = 3 experiments). Loss of heterozygosity at the q arm of chromosome 13 (which hosts the BRCA2 locus (q13.10)) in induced Li-Fraumeni-p21WAF1/Cip1
Tet-ON cells [9]. d Immunoblots depict reduced BRCA1 and BRCA2 expression in induced Saos2- and Li-Fraumeni-p21WAF1/Cip1 Tet-ON cells at
the indicated time points. α-Tubulin served as loading control. MQ mapping quality, AF allele frequency, DP sequencing depth
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unique one bearing certain similarities to signature 3.
Signature 3 is characterized by various SNSs along with
deletions and insertions of up to 50-bp stretches of
DNA with microhomologies at breakpoint junctions and
inactivating mutations in BRCA1 and BRCA2 [8]. The
“BRCAness” environment [30], following p21WAF1/Cip1
induction, along with the fact that Rad51 recombinase
expression was reduced [9], leaves Rad52 recombinase
alone to drive Rad51-independent strand-annealing.
Consistent with this notion, a strong endogenous Rad52
nuclear immunofluorescence signal was observed in
p21WAF1/Cip1-induced cells (Additional file 1: Figure S7),
reflecting foci formation that co-localized with RPA
(Fig. 5a, b), suggesting a shift to Rad52-dependent recom-
bination mechanisms [9]. In concordance with these find-
ings we recorded a fast recruitment and maintenance of
Rad52 at sites of DNA damage induced after UV irradi-
ation ablation (Fig. 5c; Additional files 7, 8, 9, and 10).
Intriguingly, the RAD52 locus was deprived of SNSs
and RAD52 protein expression was increased (Fig. 5a).
Notably, high protein levels were accompanied by
increased transcription of Rad52, which is another inter-
esting observation since most DNA repair factors are
upregulated upon DNA damage by post-transcriptional
protein modifications that are faster compared to tran-
scriptional control [31]. To obtain a mechanistic insight
into Rad52 transcriptional up-regulation, we conducted a
bioinformatic analysis of its promoter. We found that the
promoter sequence contains binding sites for several
transcriptional factors, including that for E2F1
(Additional file 1: Figure S8). Notably, we previously
showed that E2F1 is upregulated upon p21WAF1/Cip1expres-
sion, implying a putative functional link between E2F1 and
Rad52 [9]. The functionality of this potential signaling axis
was supported by chromatin immunoprecipitation (ChIP)
analysis of the Rad52 promoter showing strong E2F1 bind-
ing in p21WAF1/Cip1-induced cells (Fig. 5d). Indeed, silen-
cing of E2F1 led to reduced Rad52 expression, further
supporting the above scenario (Fig. 5e).
In yeast, Rad52 is considered the lynchpin of homolo-
gous recombination by facilitating loading of Rad51 on
single-stranded DNA (ssDNA) formed through DSB end
resection; then Rad51-coated DNA invades the sister
chromatid searching for homologous sequences forming
D-loop structures (Additional file 1: Figure S6a) [32–34].
However, in mammals, even though Rad52 retains strand-
annealing activity [35, 36], Rad51 loading is mediated
primarily by BRCA2 [37–39], implying that Rad52 may act
as a back-up mechanism. This may explain why organismal
development is unaffected in RAD52−/− mice [40, 41].
Subsequently, analyzing the distribution of SNSs guided
us in understanding which RAD52-dependent repair
process took place in the p21WAF1/Cip1-induced cells. Par-
ticularly, although at the genome-wide level the amount
of SNSs was reduced in the escaped cells, the SNSs were
interestingly clustered at the flanking regions in a number
of novel breakpoint junctions (Fig. 6a–c; Additional file 6:
Table S2). This pattern of SNS clustering is termed “katae-
gis” (Fig. 6a, b) and it requires extensive tracts of ssDNA
that act as a substrate for cytidine deamination (Add-
itional file 1: Figure S6a). The later is mediated by the
APOBEC family of enzymes leading to C∙G → T∙A
transitions and/or C∙G → G∙C transversions [7, 42].
Break-induced replication (BIR), a homologous recombin-
ation (HR)-based repair route that allows replication re-
start from collapsed replication forks [43], forms such long
ssDNA tracts, representing a candidate to repair the
p21WAF1/Cip1-induced DSBs [9, 44]. During BIR a D-loop
is formed followed by a replication fork at the one-ended
DNA DSB. The D-loop is not dissolved, but moves to-
gether with the fork (migrating bubble) [45, 46], while
DNA replication takes place in a conservative manner
[47] (Additional file 1: Figure S6a). In yeast, Rad52 seems
to play a role in BIR [48], but its role in mammals has just
started being elucidated [34, 49, 50]. Nevertheless, not all
breakpoints in the escaped cells were flanked by clustered
SNSs (Fig. 6c, d; Additional file 6: Table S2), implying that
more than one repair pathway is likely involved in
processing the p21WAF1/Cip1-induced DSBs. Since a high
frequency of microhomologies was observed in all novel
breakpoints [9], we reasoned that a putative alternative re-
pair route could be single strand annealing (SSA). SSA
mediates annealing between two ssDNA ends containing
homologous or microhomologous repeats, whereas the 3′
overhanging ends of the processed DSBs are trimmed by
XPF-ERCC1 endonuclease [51], depriving the APOBEC
editing enzymes from a single strand substrate for cytidine
deamination (Additional file 1: Figure S6b). Recently, it
was shown that cells deficient in BRCA1 and 53BP1 relied
on Rad52-dependent SSA to survive [52].
To test the above assumption we monitored DSB re-
pair using GFP reporters, in which DSBs were generated
by the nuclease I-SceI. The GFP reporters were stably
expressed in the Saos2 and Li-Fraumeni p21WAF1/Cip1-
inducible systems, and were genetically modified in a
way to monitor the main homology-dependent DSB re-
pair modes: gene conversion (GC) and particularly
synthesis-dependent strand annealing (SDSA), BIR, and
SSA [43, 53] (Fig. 7). DSB formation by I-SceI was
followed by protracted p21WAF1/Cip1 expression for a
period of 4 days. We observed that after day 4 the cells
showed stronger fluorescence signals from the GFP
reporters monitoring BIR and SSA compared to the con-
trol p21WAF1/Cip1-OFF cells (Fig. 7b, c), in contrast with the
reduced fluorescence read-out from the cells expressing
the GFP-SDSA reporter (Fig. 7a). The latter result was also
consistent with the decreased expression of key compo-
nents of the SDSA repair route seen after p21WAF1/Cip1
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expression (Fig. 4c; Additional file 1: Figure S6a). Notably,
exploiting inducible p21PCNA mutant models that cannot
interact with PCNA, we noticed that BIR- and SSA-driven
repair remained unaffected (Fig. 7b, c), confirming that the
altered repair pattern observed in cells with induced
wild-type p21WAF1/Cip1 was dependent on cellular effects
mediated by the interplay of p21WAF1/Cip1 with PCNA dur-
ing DNA replication (Fig. 7a–c). Consistent with such an
overall model was also the reduced 53BP1 loading at sites
of UV-induced DNA damage (Fig. 1e). 53BP1 fosters
homology-directed DNA repair fidelity, but its level in cells
is rate limiting, and its exhaustion signifies a shift to the
A
C
B
D
E
Fig. 5 Rad52 increased expression, recruitment, and foci formation at DSBs upon prolonged p21WAF1/Cip1 expression. a Immunofluorescent (IF)
analysis showing increased Rad52 foci formation in 96-h induced Saos2- and Li-Fraumeni-p21WAF1/Cip1 Tet-ON cells. Immunoblot (IB) and real-time
RT-PCR assessment of Rad 52 expression levels in induced Saos2- and Li-Fraumeni-p21WAF1/Cip1 Tet-ON cells at the indicated time point (*p < 0.05
(Saos2), *p = 0.05 (Li-Fraumeni), t-test; error bars indicate standard deviation; n = 3 experiments). b IF analysis showing Rad52 and RPA foci formation and
their co-localization in 96-h induced Saos2- and Li-Fraumeni-p21WAF1/Cip1 Tet-ON cells. Saos2- and Li-Fraumeni-p21WAF1/Cip1 Tet-ON cells were pre-extracted
with ice-cold PBS containing 0.2% Triton X-100 for 2 min on ice before fixation as previously described [52]. c Timelapse microscopy showing
Rad52 loading on regions of damaged chromatin after UV-laser ablation in 96-h induced Saos2- and Li-Fraumeni p21WAF1/Cip1 Tet-ON cells
transfected with the YFP-Rad52 vector. Plots depict Rad52 recruitment kinetics at sites of DNA damage in the same cells, respectively. The
average intensity of fluorescence at the site of damage and the total cell fluorescence in respect to time were quantified and plotted. Five
cells in each condition of two independent experiments were processed. d Rad52 promoter is occupied by E2F1 upon p21WAF1/Cip1 induction
in Saos2- and Li-Fraumeni-p21WAF1/Cip1 Tet-ON cells, respectively, as assessed by chromatin immunoprecipitation (ChIP; *p < 0.05, t-test; error
bars indicate standard deviation; n = 3 experiments; see also Additional file 1: Figure S8). e Silencing of E2F1 resulted in decreased Rad52 levels
as assessed by immunoblot analysis in induced Saos2- and Li-Fraumeni-p21WAF1/Cip1 Tet-ON cells, respectively (*p < 0.01, t-test; error bars indicate standard
deviation; n = 3 experiments). Actin serves as loading control; (Ctl) siRNA; arrows indicate Rad52
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error-prone SSA mechanism [52]. Collectively, these find-
ings support our working hypothesis, and given the low
levels of Rad51 and BRCA2, the data furthermore demon-
strate the inability of SDSA to deal with p21WAF1/Cip1-trig-
gered DSBs. To test the cause–effect relationship, we
silenced Rad52 to examine the dependency of BIR and
SSA on Rad52, predicted by our model. Indeed, depletion
of Rad52 led to a significant suppression of GFP fluores-
cence readouts from p21WAF1/Cip1-induced cells harboring
both the BIR- and SSA-GFP repair reporters (Fig. 7b, c),
thereby further supporting the requirement for Rad52 in
these repair pathways in our experimental settings [49, 52].
Discussion
Genome maintenance is a fundamental prerequisite for
preserving cellular life, under both physiological and
pathological conditions. Even the highly unstable aber-
rant cancer genomes must be maintained within certain
A
C D
B
Fig. 6 Single nucleotide substitutions (SNSs) cluster around chromosomal breakpoints in cells with continuous p21WAF1/Cip1 expression. a, b Diagrams
depict a dense distribution of SNSs (purple triangles) in genome areas surrounding chromosomal breakpoints (green triangles), suggestive of the kataegis
phenomenon (intense vertically lined piles of SNSs denoted by the purple triangles), relative to disparate distribution of SNSs in the remaining genome of
escaped (Esc-30 days induced), Saos2- (a) and Li-Fraumeni- (b) p21WAF1/Cip1 Tet-ON cells. Note that the total number of chromosomal breakpoints (green
triangles) depicted is double as each side of a break corresponds to a different chromosomal arm (Additional file 6: Table S2). The dashed genome areas
are depicted as magnifications of representative breakpoints. Green colored dashed areas signify representative breakpoints that show a high positional
conservation in all experimental (biological) repetitions. Position of breaks and distribution of SNSs, nucleotide insertions (INS) and nucleotide deletions
(DEL) in these examples is depicted in the corresponding subchromosomal magnifications. c, d Histograms depict the clustering frequency of SNSs (c) as
well as INS and DEL (d) over all breakpoints in the genome of escaped (Esc-30 days induced) Saos2- and Li-Fraumeni-p21WAF1/Cip1 Tet-ON cells (see also
Additional file 6: Table S2)
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limits of genomic integrity, beyond which cells would
die. Better understanding of the molecular mechanisms
that allow genome destabilization that fuels cancer
development and progression yet protect the cancer
genome from too severe, fatal instability is vital for the
development of new therapeutic strategies [6]. Replica-
tion stress (RS) driven-genomic instability emerges as a
major force promoting cancer evolution [4, 54, 55]. To
identify the DNA repair pathways that help cancer cells
adapt and survive under such chronic stress is key to
both understanding tumorigenesis and finding clinically
exploitable vulnerabilities of tumor cells.
Based on the results obtained in this study, we propose a
concept whereby chronic expression of p21WAF1/Cip1-
induces a dramatic rewiring of the cellular DNA repair
pathway choices, providing further means in conjunction
with deregulated replication to fuel genomic instability.
Using human cellular models with inducible expression of
p21WAF1/Cip1 that evokes replication stress [9], we now
show that such a scenario leads to suppression of the TLS-
A
B
C
Fig. 7 Prolonged p21WAF1/Cip1 expression promotes Rad52-dependent break-induced replication (BIR) and single strand annealing (SSA) repair of
DNA double strand breaks (DSBs). a Reduced synthesis-dependent strand annealing (SDSA) in 96-h induced Saos2- and Li-Fraumeni-p21WAF1/Cip1-
Tet-ON cells. Flow cytometry analysis (FACS) after p21WAF1/Cip1 induction in cells stably expressing a DR-GFP report vector and following I-SceI-induced
DSBs shows decreased SDSA activity (*p < 0.05, t-test; error bars indicate standard deviation; n = 5 experiments), regardless of Rad52 silencing. Similar
manipulations in Saos2- and Li-Fraumeni-p21PCNA Tet-ON cells showed no differences in SDSA in these cells. b Increased BIR activity in 96-h induced
Saos2- and Li-Fraumeni-p21WAF1/Cip1 Tet-ON cells. FACS after p21WAF1/Cip1 induction in cells stably expressing a BIR-GFP report vector and following
I-SceI-induced DSBs shows increased BIR activity (*p < 0.05, t-test; error bars indicate standard deviation; n = 5 experiments) that is suppressed upon
Rad52 silencing. Similar experiment in Saos2- and Li-Fraumeni-p21PCNA Tet-ON cells showed no effect on BIR function in these cells. c Increased SSA
activity in 96-h induced Saos2- and Li-Fraumeni-p21WAF1/Cip1 Tet-ON cells. FACS after p21WAF1/Cip1 induction in cells stably expressing an SA-GFP report
vector and following I-SceI-induced DSBs shows increased SSA activity (*p < 0.05, t-test; error bars indicate standard deviation; n = 5 experiments) that
is dependent on Rad52. A similar experiment in Saos2- and Li-Fraumeni-p21PCNA Tet-ON cells showed no effect on SSA function in these cells
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mediated repair, with ensuing defective processing of single
nucleotide lesions, eventually resulting in replication fork
stalling and collapse, generating DNA DSBs. Having in
mind that most human cancers harbor p53 and p16INK4/
pRb alterations [56], p53-independent expression of
p21WAF1/Cip1 is one of the few remaining cellular guardians
against the accumulating (pro)tumorigenic insults. Under
such circumstances, p21WAF1/Cip1-induced cellular senes-
cence is often reversible and during this temporary anti-
tumor response dramatic chromosomal remodeling takes
place that favors over time the birth of aggressive offspring
[9]. Here we provide mechanistic insights into the error-
prone repair process that occurs during this genome-
destabilizing evolutionary trajectory, by demonstrating that
p21WAF1/Cip1 induced DSBs are commonly repaired by
Rad52-dependent break-induced replication (BIR) and
single strand annealing (SSA), as the synthesis-dependent
strand annealing (SDSA) repair route was defected (Figs. 5
and 7; Additional file 1: Figure S6). BIR is a highly error-
prone homologous recombination (HR)-response that has
been implicated in formation of high-frequency tandem
segmental duplications found in cancer [7, 43]. Moreover,
BIR introduces mutations in the newly synthesized DNA
strand at a much higher rate than under conditions of con-
ventional replication [44, 57]. Likewise, SSA is associated
with extensive DNA resection contributing to genome
rearrangements and oncogenic transformation [58].
Furthermore, we show that Rad52 was upregulated
transcriptionally in a manner dependent on E2F1, a tran-
scription factor that also drives G1/S transition and
which is frequently overexpressed in cancer [59]. As the
RB pathway is almost universally deregulated in tumors,
E2F1 is often free from the restraining binding to pRB
and hence capable of inducing Rad52. This, in turn,
compensates for the reduced levels of Rad51 which is in
short supply under stressful conditions [60]. Transcrip-
tional regulation, under genotoxic stress, as seen here
for Rad52, was unexpected since most DNA damage
response and repair proteins become rapidly upregulated
via post-translational modifications that slow down the
protein turnover [31]. Given the low levels of pivotal com-
ponents (Rad51, BRCA1, and BRCA2) of the SDSA repair
machinery (Fig. 4c, d; Additional file 1: Figure S6a), the
p21WAF1/Cip1 expressing cells resort to transcriptional up-
regulation of Rad52, a fact that reflects the increased repair
needs required to cope with the p21WAF1/Cip1-driven repli-
cation stress [61]. On the other hand, post-translational
modifications of the chromatin bound fraction of Rad52
cannot be excluded, as recently reported [49], and could
further contribute to increased abundance of Rad52.
In contrast to yeast, where Rad52 represents a major
factor in the first line of genome maintenance [33], in
higher eukaryotes and mammals Rad52 seems to serve
as a reserve player that can substitute for other repair
options when those are compromised. Overall, this con-
cept highlights Rad52 as a potential therapeutic target in
tumors with inactive BRCA2 and helps explain why
Rad52 gene amplifications are selected for in human
cancers [62–64]. Thus, targeting Rad52 could turn out
to be a new way to therapeutically exploit vulnerabilities
that occur selectively in cancer cells. Consistent with this
idea, depletion of Rad52 confers synthetic lethality in
BRCA2 deficient cells [65, 66].
Conclusions
On the whole, the current study broadens our under-
standing of how chronic p53-independent p21WAF1/Cip1
expression, seen in a sizeable fraction of advanced human
tumors [9], impacts the global DNA repair landscape and
undermines genomic stability. The salient features of our
model are the following: i) saturation of the CRL4CDT2-
ligase complex by p21WAF1/Cip1 impairs the turn-over of
the replication licensing factors leading to their unsched-
uled accumulation, causing ii) genome re-replication and
replication stress, as recently described [9], while iii)
concurrent suppression of the DNA damage tolerance
(TLS) pathway reduces the repair rate of the nucleotide
lesions in an environment with dysfunctional error-free
excision repair mechanisms of BER, NER, and MMR. As a
consequence of such grossly rewired DNA repair pathway
choice, the rate of unrepaired nucleotide lesions increases,
further raising the burden on the already limited TLS.
Both features of DNA re-replication-induced replication
stress and deficient TLS lead to enhanced formation of
the highly deleterious DSBs that are repaired in an error-
prone manner, by Rad52-dependent BIR and SSA, thereby
fueling genomic instability and promoting cancer develop-
ment (Fig. 8). We hope the concept proposed here may
not only inspire further mechanistic studies, but also
attempts to target Rad52 in cancer, as a way to selectively
induce lethal chromosomal instability in Rad52-
dependent cancers, while sparing normal tissues whose
genome maintenance does not depend on Rad52. Lastly,
the present study underscores the significance of identify-
ing mutational signatures as they can unveil the repair
procedure(s) that fuel genomic instability and thus high-
light potential therapeutic targets for cancer treatment.
Methods
Cell lines and culture conditions
Inducible p21WAF1/Cip1 Tet-ON cell lines—Saos2-
p21WAF1/Cip1 Tet-ON and Li Fraumeni- p21WAF1/Cip1 Tet-
ON—were maintained in High Glucose DMEM (Biosera)
supplemented with 10 % Tet System Approved FBS
(Clontech) and 100 μg/ml penicillin and streptomycin
(Invitrogen) and incubated at 37 °C and 5 % CO2. Induc-
tion of p21WAF1/Cip1 was conducted by treatment of the
cell culture with 1 μg/ml doxocycline (Applichem) [9].
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siRNA and vector transfections
Rad52 (Thermo Scientific) siRNA gene silencing was
performed as previously described, following the manu-
facturer’s instructions [9]. YFP-RAD52 [52] and Polκ
vectors were transfected as previously described [67].
Protein extraction, cell fractionation, and immunoblotting
Protein extraction and cell fractionation were performed as
described before [9]. Thirty micrograms of protein from
total extracts per sample were adjusted with Laemmli buffer
(Sigma) and loaded on acrylamide/bis-acrylamide gels. Gel
electrophoresis, transfer to PVDF membrane (Millipore),
and signal development with nitro blue tetrazolium/5-
bromo-4-chloro-3-indolylphosphate (NBT/BCIP) solution
(Molecular Probes) or chemiluminescence were performed
as previously described [9]. Alkaline phosphatase-conjugated
anti-mouse or anti-rabbit as well as horse radish peroxidase
conjugated anti-mouse, anti-rabbit, and anti-sheep second-
ary antibodies (1:1000 dilution; Cell Signaling) were used.
Primary antibodies utilized were anti-p21WAF1/Cip1
(mouse, Santa Cruz, sc-6246, 1:400 for IB), anti-RAD52
(mouse, Santa Cruz, sc-365,341, 1:100 for IF), anti-β-actin
(rabbit, Cell Signaling Tech, 4967 s, 1:1000 for IB), anti-
PCNA (mouse, Cell Signaling Tech, 2586 s, 1:1000 for IB),
anti-Ubiquityl-PCNA (rabbit, Cell Signaling Tech, 13,439
s, 1:1000 for IB), anti-polη (rabbit, Santa Cruz, sc5592,
1:200 for IB), anti-BRCA1 (mouse, SantaCruz, sc6954,
1:200 for IB), anti-BRCA2 (mouse, Merck Millipore,
OP95, 1:200 for IB), anti-DDB1 (mouse, Abcam, ab13562,
1:1000 for IB), anti-LIG3 (rabbit, Abcam, ab185815,
1:1000 for IB), anti-APEX1 (mouse, Abcam, ab194, 1:2000
for IB), anti-TDG (mouse, Novus Biologicals,
NBP2–43717, 1:5000 for IB), anti-MUTY (rabbit, Thermo
Fisher Scientific, PA5–26167, 1:1000 for IB), anti-ERCC1
(mouse, SantaCruz, sc17809, 1:1000 for IB), anti-ERCC4-
XPF (mouse, Thermo Fisher Scientific, MA5-12060, 1:500
for IB), anti-ERCC5-XPG (rabbit, Abcam, ab189317, 1:500
for IB), anti-XPC (mouse, Santa Cruz, sc-74,410, 1:500 for
IB), anti-XRCC1 (mouse, Abcam, ab1838, 1:200 for IB),
anti-NEIL2 (rabbit, Abcam, ab124106, 1:500 for IB), anti-
α-tubulin (mouse, GeneTex, GTX628802, 1:5000 for IB),
anti-β-tubulin (rabbit, Abcam, ab6046, 1:1000 for IB),
anti-lamin B1 (rabbit, Abcam, ab16048, 1:1000 for IB). All
analyses were performed in triplicate.
Fig. 8 Proposed model depicting how p53-independent p21WAF1/Cip1 expression fuels Rad52-dependent error-prone double strand break repair
promoting genomic instability. Sustained p53-independent p21WAF1/Cip1 induction leads to increased levels of nucleotide lesions mediated by elevated
reactive oxygen species (ROS). Given the negative impact exerted by p21WAF1/Cip1 on the error free nucleotide repair mechanisms (BER and
NER), a significant proportion of such base lesions escape unrepaired. This creates an additional repair “load” to the error prone repair mechanism of
TLS, which is further compromised by p21WAF1/Cip1 overexpression, leading to a decreased SNS load and in favor of DSBs. In turn, this further increases
the DSB burden generated also through re-replication [9]. As components of SDSA are down-regulated, a shift to Rad52-mediated error prone
DNA repair takes place by invoking the BIR and SSA repair routes, fueling genomic instability. This repair switch is mediated by a shift in the
balance between Rad51 and Rad52 levels as the former is suppressed by E2F4 [9] and the latter is induced by E2F1 (present study). DSB DNA
double strand break, BER base excision repair, NER nucleotide excision repair, TLS translesion DNA synthesis and repair, SDSA synthesis-dependent
strand annealing, BIR break-induced repair, SSA single strand annealing
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Indirect immunofluorescence
Indirect immunofluorescence analysis was performed as
previously published [9]. Regarding identification of
RAD52 foci, parameters of the aforementioned process
have been set as indicated by Ochs and collaborators
[52] and by Sotiriou and collaborators [49]. For all RPA
and Rad52 IF co-localization experiments (Fig. 5b)
Saos2- and Li-Fraumeni-p21WAF1/Cip1 Tet-ON cells
were pre-extracted with ice-cold PBS containing 0.2%
Triton X-100 for 2 min on ice before fixation as previ-
ously described [52]. Secondary antibodies were Alexa
Fluor 488 donkey anti-sheep (Abcam, ab150177, 1:500)
and Alexa Fluor 568 goat anti-mouse (Invitrogen, no.
A11031, 1:500). Image acquisition of multiple random
fields was automated on a DM 6000 CFS Upright
Microscope (Confocal Leica TCS SP5 II) or a ScanR
screening station (Olympus) and analyzed with ScanR
(Olympus) software, or a Zeiss Axiolab fluorescence
microscope equipped with a Zeiss Axiocam MRm cam-
era and Achroplan objectives, while image acquisition
was performed with AxioVision software 4.7.1. Primary
antibodies utilized were anti-p21WAF1/Cip1 (mouse,
Santa Cruz, sc-6246, 1:200 for IF), anti-RAD52 (sheep
[52], 1:100 for IF and mouse, Santa Cruz, sc-365,341,
1:100 for IF). All analyses were performed in triplicate.
Image acquisition
Live DNA damage protein recruitment kinetics were
observed using an Olympus IX83 inverted microscope
system. DNA irradiation damage was induced on the
same system using a coupled UVA (355 nm) pulsed
laser (teemphotonics PNV-M02510) and a theoretical
pulse duration of less than 350 psec. Subnuclear irra-
diations were performed on an 8-μm linear ROI with
the use of a total of 60–90 pulses subdivided into
three repeats, with 2.3 % of the total laser power.
Pulse irradiation calibration was titrated through
γH2Ax post damage spatial organization on MCF7
cancer cells as previously described [68]. For time-
lapse acquisition an Olympus Apochromat 63×/ 1.2NA
water immersion lens and a Hamamatsu ORCA Flash
4.0. sCMOS camera system were used. The micro-
scope was equipped with a temperature/humidity and
CO2 incubation system (CellVivo) and with a 6-LED
system (Lumencor) as light source.
Brief powerful laser ablation inscribed cell location
within the glass volume of the coverslip below the cells
of interest. This technique enables easy location of the
marked fields of view on any microscope under trans-
mission contrast.
Z-stack imaging was conducted on a Leica SP5 TCS
equipped with a hybrid detector and a 60×/1.4NA oil
immersion lens. A z-step of 0.72 μm was used and a
total of 18 stacks were obtained per nucleus.
Cell culture
For live-cell experiments, cancer cells were plated on
Ibidi glass bottom dishes (idibi μ-dish 35 mm 81,156) in
phenol red-free, Minimum Essential Medium Eagle
(MEM). L-glutamine 2 mM, hepes 25 mM final concen-
tration, and 10 % fetal bovine serum (FBS) were added.
Image analysis
Kinetics analyses were quantified using Fiji distribution
of ImageJ (v 2.0.0-rc-30/1.49 s). Images were background
corrected by subtracting the mean intensity value of an
area outside the cell (ROI3). Values of corrected mean
intensity of the site of damage (RO1’) and the corrected
total fluorescent-area mean intensity were obtained at
each time point (ROI2’). Cells were normalized for the
different protein expression levels and acquisition photo-
bleaching with the use of this formula:
I tð Þdoublenorm ¼
1
npre

Xnpre
i¼1
I tð ÞROI20
I tð ÞROI20
0
BBBB@
1
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 I tð ÞROI10
1
npre
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0
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ChIP assay
ChIP assay was performed as previously described [67].
A 130-bp fragment in the Rad52 promoter and a 140-bp
amplicon, located approximately 1000 bp from the tran-
scription start site (Fig. 5d), were amplified. Primers and
annealing temperatures are provided in Additional file 6:
Table S3. PCR reactions containing 1 % of the total
chromatin extract used in the immunoprecipitation re-
actions were used as inputs. Three independent assays
were performed.
TLS assay
Cells were co-transfected with a plasmid mixture con-
taining the gap-lesion plasmid (kanR), a control gapped
plasmid without a lesion (cmR), and the carrier plasmid
pUC18 (ampR). After allowing time for gap filling and le-
sion bypass, plasmids were extracted using alkali, such
that only filled-in plasmids remained intact. To assay the
fraction of filled-in plasmids, the plasmid mixture was
transformed into an indicator Escherichia coli recA
strain and plated in parallel, on LB-kan plates (to select
for plasmids that underwent TLS) and LB-cm plates (to
select for the control filled-in plasmid GP20-cm). TLS in
this case was calculated by the ratio of kanR/cmRE. coli
transformants. Specifically, the cells were co-transfected
with a DNA mixture containing 100 ng of a gap-lesion
plasmid (GP BP-G; kanR), 100 ng of a gapped plasmid
without lesion (GP20-cm, cmR), and 2300 ng of the car-
rier plasmid pUC18, using Lipofectamine®2000/DNA
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complexes. The percentage of lesion bypass gap filling
was calculated by dividing the number of GP BP-G trans-
formants (number of colonies on LB-kan plates) by the
number of corresponding GP20-cm transformants (num-
ber of colonies on LB-cm plates). When desired, plasmids
were extracted from kanR colonies, and the sequence
opposite the lesion was determined by DNA sequence
analysis [18].
Comet assay
In order to determine the endogenous (background) levels
of oxidatively induced DNA damage we performed the
sensitive technique of single cell gel electrophoresis
(SCGE; Comet assay) under alkaline (denaturing) condi-
tions as previously described [67]. We also used as a DNA
damage probe the human repair enzyme OGG1 (New
England Biolabs) to detect the specific presence of 8-oxo-
dGuanine (8-oxo-dG) [24]. An increase in the tail moment
(TM) suggests higher levels of oxidative DNA damage
(primarily oxidized purines). Cells were observed under a
Zeiss Axiolab fluorescence microscope equipped with a
monochrome CCD camera. Analysis was conducted with
Cometscore software (Tritek). All experiments were
performed five times.
Melphalan assay
Melphalan [(4-(bis{2-chloroethyl} amino)-l-phenylalanine]
belongs to the nitrogen mustard class of chemotherapeu-
tic agents, used in the treatment of certain hematological
maligancies. The monofunctional derivative of melphalan
(monohydroxymelphalan) induces only monoadducts,
which are almost exclusively repaired by nucleotide exci-
sion repair [69–71]. Its mode of action is by alkylating the
DNA, generating predominantly N-alkylpurine monoad-
ducts and to a minor extent interstrand cross-links (ICLs),
the formation of which are dependent on these monoad-
ducts. These lesions primarily affect the N-7 position of
guanines and to a lesser degree the N-3 position of
adenines.
Preparation of the monofunctional derivative of mel-
phalan was performed as described previously [69, 70].
Cell lines were treated with monohydroxymelphalan
(100 μg/ml, 5 min, 37 °C) in culture medium. Then, cells
were incubated in drug-free medium for various times
(up to 48 h), harvested, and stored at −70 °C.
To measure the induction and repair of melphalan-
derived DNA adducts, a specific assay is applied [26]. In
principle, the N-ras-specific nucleotide excision repair was
evaluated by the monofunctional binding of monohydroxy-
melphalan to a single site in the DNA molecule (monoad-
ducts) at various time points as described previously [71].
Briefly, genomic DNA was digested to completion with the
restriction enzyme EcoRI and DNA samples dissolved in
sterile deionized H2O were heated at 70 °C for 30 min to
depurinate N-alkylated bases. Apurinic sites were con-
verted to single strand breaks by the addition of NaOH for
30 min at 37 °C, size fractionated using agarose gel electro-
phoresis, and Southern blotted. Hybridizations were
performed as described previously. The average frequency
of N-ras-specific monoadducts in the restriction fragment
of interest was calculated from the fraction of DNA in the
band from the treated sample compared to that from the
non-treated sample. To minimize the inaccuracy in the
measurement of DNA damage arising from errors in DNA
quantification or gel loading, in all experiments an internal
standard (part of the N-ras gene) was included. Data were
obtained from five independent experiments with two
repetitions for each time point in each experimental set.
8-Oxo-dG assay
A previously described assay based on the property of
avidin to bind with high specificity to 8-oxo-dG was used
for the 8-oxoG measurements [24]. Briefly, cells were
fixed in methanol at −20 °C for 20 min and incubated for
15 min in TBS, 0.1 % Triton X-100. Blocking was per-
formed in 15 % FBS, 0.1 % Triton X-100 in TBS for 2 h at
room temperature (RT). Cells were then incubated with
10 μg/ml Alexa488-conjugated avidin (Invitrogen) in
blocking solution for 1 h at 37 °C. Next they were rinsed
twice in TBS, 0.1 % Triton X-100 for 5 min each round at
room temperature. After a quick rinse in distilled water,
DNA was counterstained with ToPro3-Iodide (Life-
Technologies) for 15 min at room temperature, followed
by a final rinse in TBS.
Coverslips were mounted with ProLongGold (Invitro-
gen) and cells were observed under a Zeiss Axiolab
fluorescence microscope equipped with a monochrome
CCD camera. Analysis was conducted with NIH-imageJ,
with respect to mean intensity in the nucleus (To-Pro3
served as a DNA reference). All experiments were
repeated five times.
Measurement of intracellular levels of reactive
oxygen species
Intracellular levels of reactive oxygen species (ROS) were
calculated using the DCFH-DA assay. In details, the cells
were plated in a 96-well plate at a density of 10,000 cells/
well and when ~ 80 % confluent they were treated with
doxocycline (1 μg/ml) in DMEM supplemented with 10 %
(v/v) FBS until confluence. At the indicated time points
DCFH-DA (10 μM) was added and after a further incuba-
tion of 1 h measurements (excitation wavelength 480 nm,
emission wavelength 530 nm) were taken in a FLUOStar
OPTIMA microplate reader (BMG Labtech GmbH,
Ortenberg, Germany) using the MARS Data Analysis
Software. After this measurement, the number of cells was
estimated and ROS levels were expressed as fluorescence
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units per cell number [72]. Average data from five inde-
pendent experiments were obtained.
cDNA preparation and real-time quantitative PCR with
reverse transcription
cDNA generation and real-time quantitative PCR with re-
verse transcription analysis were performed as described
before [9]. The reaction was performed in a StepOne Real
time machine (Life Technologies) using Universal Master-
Mix II without UNG containing SYBR (Life Technologies)
and 200 nM primers. Signal analysis was carried out using
the StepOne v2.3 software. Primers and annealing temper-
atures are provided in Additional file 6: Table S3. All
analyses were performed in triplicate.
DR-GFP, SA-GFP, and BIR-GFP reporter assays
Saos2-p21WAF1/Cip1 Tet-ON cells harboring the GFP based
reporter constructs for synthesis-dependent strand anneal-
ing (DR-GFP), single strand annealing (SA-GFP), and
break-induced replication (BIR-GFP) were generated by
transfection with these DSB repair reporters
(Additional file 6: Table S4), followed by selection of stably
transfected clones [43, 53]. To monitor the repair of an I-
SceI-generated DSB, cells were transiently transfected with
1 μg of the I-SceI expression vector HA-ISceID44A
(Addgene #59424) with effectene transfection reagent
(Qiagen). DSB repair efficiency, upon induction of
p21WAF1/Cip1, was determined by quantifying GFP-positive
cells via flow cytometry FACS Calibur (Becton Dickinson)
48 h after transfection. Data were obtained from five inde-
pendent experiments.
High-throughput whole-genome analyses
Whole-genome sequencing analysis
Whole-genome sequencing (WGS) library preparation,
alignment, and breakpoint identification were performed
as described before [9]. Samtools mpileup and vcftools
[73] were used for identification and filtering of the
SNSs and INDELs. SNSs and INDELs that were unique
in the escaped cells were normalized based on the depth
of the sequencing for each experiment. In more detail
we generated .bam files with the use of bowtie2 (“–very-
sensitive”) and samtools (“view” command). We used the
.bam files to extract the SNSs and INDELs with the use
of samtools (“mpileup” command) and bcf/vcf tools to
convert generated .bcf files to .vcf and separate the SNSs
from the INDELs. VCF files containing SNSs and
INDELs were filtered based on their mapping quality
(MQ ≥ 30) while “genotypes” (GT) (0/1 = 1 allele and 1/
1 = both alleles) corresponding to allele frequency
greater than 0.5 (AF ≥ 0.5) were kept for downstream
analysis. The algorithms for measuring the SNS load and
identifying the mutational signatures are schematically
presented in Additional file 1: Figure S1 and described
as follows.
SNS load
The SNS load was calculated after filtering for mapping
quality (MQ ≥ 30), allele frequency (AF ≥ 0.5), and
sequencing depth (DP) of the total number of SNSs
identified with the use of Samtools and VCF tools for
each of the eight WGS experiments (n = 8). For read
depth normalization in the WGS experiment we calcu-
lated the coverage of the aligned reads in the effective
human genome and selected those SNSs and INDELs
with read-depth equal to the average normalized cover-
age for each experiment.
Mutational signature
Mutational signature was performed with the use of the
SNSs that were filtered for mapping quality in both
escaped (Esc)/non-induced (OFF) cells. After intersecting
the SNSs in the escaped cells with the SNSs in the non-in-
duced (OFF) cells applying the bedtool algorithm (“inter-
sectBed”) [74] we used the newly identified SNSs (Esc-
specific as shown in Additional file 1: Figure S1), which we
filtered for allele frequency and read depth. The newly
identified SNSs were employed for generating the mutation
signature of the escaped cells. By applying intersection be-
tween the two cell populations and then filtering based on
read depth and allele frequency we removed any bias due
to low coverage in OFF cells and focused on SNSs that ap-
peared only in the escaped cells.
RNA-seq analysis
RNA was collected from non-induced and 96-h induced (4
day) Saos2 p21 Tet-ON cells, as well as from non-induced
and 96-h induced (4 day) Li-Fraumeni p21 Tet-ON cells
(three biological replicates for each condition). RNA-seq li-
brary preparation and analysis of 75-bp paired-end reads
procedure was performed in the Greek Genome Center
(GGC) of Biomedical Research Foundation of Academy of
Athens (BRFAA). TopHat2 (2.0.9) [75] was used for data
alignment with the use of “- - sensitive” option to the hg19
genome version, while HT-seq count algorithm [76] was
used for assigning aligned reads to the human transcrip-
tome. Identification of the differentially expressed genes
was performed with R/Bioconductor and DESeq [77]
algorithm and genes with absolute fold change ≥ 1.5 and p
value ≤ 0.05 were considered as differentially expressed
between induced and non-induced cells.
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